Calliditas refinances existing term loan with Euro 92 million senior secured facility with Athyrium Capital
Calliditas Therapeutics AB (Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the company has signed and fully drawn a term loan…